Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT05655897
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT05655897
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT05655897. Allocation not applicable; no masking; primary purpose treatment. Start 2022-11-24 (actual); primary completion 2025-11-24 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation
- Condition
- Mitral Regurgitation
- Condition
- Degenerative Mitral Valve Disease
- Intervention (Device)
- GeminiOne Transcatheter Valve Edge-to-Edge Repair System
- Lead sponsor
- Peijia Medical Technology (Suzhou) Co., Ltd.
Record details
- Record id
cardio:ct-nct05655897- Content hash
fa0bf065c2ca60373f6957708f262f7296c18658e07722a2a04518562139432e